Navigation Links
Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action
Date:11/6/2007

BETHESDA, Md., Nov. 6 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced the publication of two new studies describing a unique mode of action of Micromet's bispecific BiTE antibody therapeutics. The studies were published in the Journal of Immunotherapy(1) and in Cancer Immunology Immunotherapy(2), respectively.

BiTE antibodies are designed to transiently connect cytotoxic T cells with cancer cells leading to a tightly controlled and serial elimination of cancer cells. In this process, cytotoxic T cells are activated, which causes them to proliferate, recharge their toxins and increase their adhesiveness.

The two new studies have shown that BiTE antibodies activate T cells only when cancer cells are present, but not when they are given to T cells in the absence of cancer cells. The studies have also shown that initial cytokine release by activated T cells is not required for elimination of cancer cells, and that anti-inflammatory steroid hormones can efficiently quench the initial cytokine release by BiTE-activated T cells without reducing their capacity to kill cancer cells.

"The highly conditional, target cell-dependent activation of killer T cells by our BiTE antibodies is a very important safety feature in patients," commented Patrick Baeuerle, Micromet's Chief Scientific Officer. "Unlike other T cell-activating agents, BiTE antibodies activate T cells in a highly controlled fashion that is intimately linked to the desired therapeutic activity."

"We have observed depletion of circulating B lymphoma cells and have confirmed partial and complete responses in the clinical trials with MT103. At the same time, only very low systemic cytokine levels, if any, were detected," commented Carsten Reinhardt, Micromet's Chief Medical Officer. "The side effect profile of MT103 seen in the ongoin
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Scripps Research scientists shed new light on how antibodies fight HIV
2. Brain imaging reveals breakdown of normal emotional processing
3. Survey reveals disparities in skin cancer knowledge, protection among high school students
4. Large intensive care study reveals vital recommendations for treatment of brain injury patients
5. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
6. Inc. Magazine Reveals Its 26th Annual List of Americas 500 Fastest-Growing Private Companies
7. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
8. Trade-offs reveal no clear favorites in alternative energy market
9. Revealing the workings of Mother Natures blowtorch
10. Scientists reveal DNA-enzyme interaction with first ever real time footage
11. New Survey Reveals Kidney Patients Concern About Medicare Policies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to announce ... Services at North Carolina State’s College of Veterinary Medicine ... Award for Distinguished Volunteer Service—the organization’s highest award. ... of volunteer experts to direct its work to improve ...
(Date:1/22/2015)... West Hollywood, California (PRWEB) January 22, 2015 The ... 22, 2015 at 10 a.m., to commemorate the 42nd anniversary of ... the United States. , “It’s been 42 years since the Roe ... to choose is still as present as ever,” said City of ...
(Date:1/22/2015)... AZ (PRWEB) January 22, 2015 Padre Murphy's ... long supporter of Pro Player Health Alliance (PPHA). ... Padre Murphy's in getting everyone, including NFL greats, treated for ... of the leading groups supporting the cause in the valley. ...
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... smallpox, which kills about 30% of its victims and leaves ... of exposure can protect against illness. A French drug company ... smallpox vaccine and the United States said it would accept ... disease. // ,The UnitedStates has been working to gather ...
... drawn another blank in their search for a universally ... new approaches to researching the illness. A paper by ... findings to the contrary, there is no close link ... chromosome 1.// ,The researchers scoured the chromosome in ...
... United States and is prescribed as a long-term painkiller ... to slowly release its active ingredient, oxycodone, to control ... pill is chewed or crushed and sniffed, it gives ... and dangerous. ,The controversial Purdue Pharma painkiller OxyContin ...
... researchers in Dallas, using disinfectant gels, rather than hand rubs, ... hygiene. Getting doctors and nurses to wash their hands between ... reducing hospital infections.// Soap and water is used in US, ... have drawbacks soap and water is time consuming, the rubs ...
... The government and researchers are warning that blood transfusions ... has been linked to more than 50 deaths// nationwide ... about 4.5 million patients receive transfusions each year. Testing ... not part of routine screening of the nation's blood ...
... US Food and Drug Administration approval for use in ... at high risk for heart attack, typically because they ... 1.1 to 1.4 million Americans experience acute coronary syndrome ... 1997 for patients with a recent heart attack, stroke ...
Cached Medicine News:Health News:No explanation on schizophrenia gene 2
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
(Date:1/22/2015)... Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today announced ... financial results on Tuesday, Jan. 27, 2015, after the close of ... conference call with the investment community at 2 p.m. PT. Participating ... , chairman and chief executive officer, and other members of Amgen,s ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... South Dakota pharmaceutical company, pharmaCline ™ , has launched ... statement.  On November 23, 2011, pharmaCline became a part ... spot on the CBS jumbo screen located in Times ... through January 1, 2012. (Logo:  http://photos.prnewswire.com/prnh/20111202/MN16158LOGO ...
... Dec. 1, 2011 Demands from senior management ... commercial functions searching for best-in-class organizational structures. Comparing ... in place at peer companies through benchmarking data ... To support pharmaceutical vice presidents, directors, ...
Cached Medicine Technology:pharmaCline Launches "pharmaCline Can Help" Campaign 2Organizational Design and Structure Benchmarks for Pharmaceutical Commercial Functions Accessed Quickly Through Best Practices, LLC's New Database Search Function 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: